Sadatpoor Seyyed Omid, Salehi Zahra, Rahban Dariush, Salimi Ali
Nanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Immunology Department, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Int J Stem Cells. 2020 Mar 30;13(1):24-45. doi: 10.15283/ijsc19031.
Mesenchymal stem cells (MSCs) are multipotent stem cells that have multilinear differentiation and self-renewal abilities. These cells are immune-privileged as they express no or low level of class-II major histocompatibility complex (MHC-II) and other costimulatory molecules. Having neuroprotective and regenerative properties, MSCs can be used to ameliorate several intractable neurodegenerative disorders by affecting both innate and adaptive immune systems. Several manipulations like pretreating MSCs with different conditions or agents, and using molecules derived from MSCs or genetically manipulating them, are the common and practical ways that can be used to strengthen MSCs survival and potency. Improved MSCs can have significantly enhanced impacts on diseases compared to MSCs not manipulated. In this review, we describe some of the most important manipulations that have been exerted on MSCs to improve their therapeutic functions and their applications in ameliorating three prevalent neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and Huntington's disease.
间充质干细胞(MSCs)是具有多向分化和自我更新能力的多能干细胞。这些细胞具有免疫特权,因为它们不表达或低水平表达II类主要组织相容性复合体(MHC-II)和其他共刺激分子。由于具有神经保护和再生特性,MSCs可通过影响固有免疫系统和适应性免疫系统来改善多种难治性神经退行性疾病。几种操作方法,如用不同条件或试剂预处理MSCs、使用源自MSCs的分子或对其进行基因操作,是可用于增强MSCs存活能力和效力的常见实用方法。与未处理的MSCs相比,经过改良的MSCs对疾病的影响可显著增强。在这篇综述中,我们描述了一些对MSCs进行的最重要操作,这些操作可改善其治疗功能,以及它们在改善三种常见神经退行性疾病(包括阿尔茨海默病、帕金森病和亨廷顿病)中的应用。